SAB Biotherapeutics Semi Deviation

SABS Stock  USD 4.09  0.29  7.63%   
Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level. Below is SAB Biotherapeutics's current Semi Deviation with peer comparisons and related risk metrics.

Current Semi Deviation Value

SAB Biotherapeutics has a Semi Deviation of 3.92, indicating moderate price variability. This places SAB Biotherapeutics within the typical volatility range for Stock.

Semi Deviation

=

SQRT(SV)

 = 
3.92
SQRT = Square root notation
SV =   SAB Biotherapeutics semi variance of returns over selected period

Semi Deviation Peers Comparison

The peer group averages 7.04 for Semi Deviation, with SAB Biotherapeutics at 3.92 falling below that level. Readings span 1.62 (Boundless Bio Common) to 23.73 (Iterum Therapeutics PLC). SAB Biotherapeutics has exhibited less price dispersion than the peer average over the measured period.

Semi Deviation Relative To Other Indicators

The chart below plots Semi Deviation against Maximum Drawdown for SAB Biotherapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Semi Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Comparing Semi Deviation ( 3.92 ) to Maximum Drawdown ( 21.29 ) for SAB Biotherapeutics yields a 5.43 multiple. This indicates Maximum Drawdown substantially exceeds Semi Deviation for SAB Biotherapeutics.
Compare SAB Biotherapeutics to Peers

Methodology, Assumptions & Data Sources

SAB Biotherapeutics has a current Semi Deviation reading of 3.92. Semi Deviation for SAB Biotherapeutics is derived by applying a defined formula to historical price observations, producing a time-series of comparable readings. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. Indicator accuracy depends on data continuity across the calculation period. Gaps in trading history may affect the output.

Other Technical Indicators